ReviewWMJ : official publication of the State Medical Society of Wisconsin2011
Escherichia coli pyomyositis in an immunocompromised host.
Review in WMJ : official publication of the State Medical Society of Wisconsin, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 14 citations in OpenAlex.
- Multifocal Abdominal Pyomyositis From Subcutaneous Dissemination in an Immunocompetent Patient.Cureus · 2022Article
- Article
- Isolation and Identification of Non- Commensal Pathogenic Bacteria in the Saliva of Patients Candidate for Liver Transplant: A Cross Sectional Study in Shiraz, South of Iran.Journal of dentistry (Shiraz, Iran) · 2020Article
- Enhanced Survival of Rifampin- and Streptomycin-Resistant Escherichia coli Inside Macrophages.Antimicrobial agents and chemotherapy · 2016Article
- Development of bilateral gluteal pyomyositis during treatment of acute pyelonephritis in a patient with diabetes.The Korean journal of internal medicine · 2015Article
- Acromioclavicular septic arthritis and sternoclavicular septic arthritis with contiguous pyomyositis.Clinics in orthopedic surgery · 2015Article
- Epidemiology of infections in cancer patients.Cancer treatment and research · 2014Review
- Enterobacter cloacae pyomyositis complicating chronic granulomatous disease and review of gram-negative bacilli pyomyositis.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2013Review
- The genetic basis of Escherichia coli pathoadaptation to macrophages.PLoS pathogens · 2013Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
Abstract
backgroundPyomyositis due to Escherichia coli (E. coil) is rarely reported in immunocompromised patients with hematological malignancy. CASE REPORT: We present a case report of a 34-year-old man who developed E. coli pyomyositis as a complication of acute myelogenous leukemia (AML). Magnetic resonance imaging (MRI) of the right hip suggested myofascial infection of the gluteal muscles, and a needle muscle aspiration grew E. coli phylogenetic group B2. The patient responded to intravenous piperacillin/tazobactam followed by prolonged oral levofloxacin.
conclusionPyomyositis should be suspected in all immunocompromised patients complaining of muscle pain and may exhibit signs of localized muscle infection. Appropriate antibiotic therapy targeting fluoroquinolone-resistant E. coli should be considered for initial empiric therapy of pyomyositis in immunocompromised patients.
Indexed as
Identifiers
22413629PMC4441203W315226252What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.